Transendothelial migration (TEM)
Transendothelial migration (TEM) is a mechanism by which the endothelium may play a role in asthma or COPD. Neutrophils play an important role in the inflammatory response in COPD [
14]. In order to reach the lung tissue neutrophils must bind to, and migrate through, the endothelium [
13]. Initially neutrophils extend part of themselves (pseudopod) to invaginate the apical endothelial cell membrane. The neutrophil binds to the endothelial cell through a variety of cell surface proteins before migrating between the endothelial cells [
13]. This is known as paracellular transmigration and is illustrated in Fig.
1 [
13]. However, neutrophils can also transmigrate through endothelial cells in a process known as transcellular transmigration [
13]. These cell surface proteins (or cell adhesion molecules) extravasate into inflamed tissue after TEM which means they are detectable in the serum [
15]. Soluble cell adhesion molecule levels also correlate with cellular adhesion molecule levels thereby enabling an indirect assessment of cellular adhesion molecule levels [
16].
TEM appears to be upregulated in COPD and macrophage-1 antigen (MAC-1), a protein involved in TEM is upregulated in neutrophils from COPD patients [
17]. MAC-1 binds to intracellular adhesion molecule-1 (ICAM-1) on the surface of endothelial cells. Serum levels of ICAM-1 are inversely related to lung function and are also associated with increased percentages of emphysema on CT scan suggesting that this mechanism may be clinically relevant [
18,
19]. Blocking the action of ICAM-1 in rodent models has also reduced pulmonary inflammation further supporting the possibility that the increase in ICAM-1 might be related to the increase in inflammation seen in COPD [
20]. In addition, endothelial-leucocyte adhesion molecule-1 (ELAM-1) (another adhesion molecule involved in TEM) is also upregulated in serum in COPD patients and is particularly high in patients with chronic bronchitis further supporting the involvement of adhesion molecules in lung inflammation and COPD pathogenesis [
21]. Another possible explanation for the increase in TEM in COPD is endothelial dysfunction (see below). Endothelial dysfunction is increased in COPD and appears to induce the expression of cell adhesion molecules [
22].
TEM also appears to be of importance in asthma. For example, mice deficient in cell adhesion molecules L-selectin and ICAM-1 show a reduced influx of inflammatory cells into the lung and a reduction in AHR on exposure to an ovalbumin challenge [
23]. In addition, in vitro studies of sensitized human bronchial tissue have demonstrated an increase in the expression of endothelial adhesion molecules (such as ICAM-1) in response to allergen exposure [
24]. Gosset et al. also showed an increase in endothelial adhesion molecules in bronchial biopsies of patients with allergic asthma in comparison to controls [
25]. Cell adhesion molecules in eosinophils also appear to be upregulated in asthma. Ohkawara et al. showed that eosinophils in bronchial biopsies from asthmatic patients strongly expressed MAC-1, Lymphocyte function-associated antigen 1 (LFA-1) and Very Late Antigen-4 (VLA-4) [
26]. In a similar way to COPD, inflammation and underlying endothelial dysfunction could also potentially provide an underlying cause of increased adhesion molecule levels seen in asthmatic patients [
20,
22].
The absolute level of adhesion molecules may not be the only factor of importance in TEM in asthma. Different alleles of adhesion molecules may predispose to asthma. For example the PECAM-1 (platelet endothelial cell adhesion molecule-1) 125 Val/leu polymorphism is more frequent in asthma patients in comparison with controls [
27].
In addition to inflammation and endothelial dysfunction, another possible mechanism of increased TEM in asthma is upregulation of chemokines. Endothelial cells in asthma appear to increase production of chemokines to attract and activate circulating eosinophils. For example, Eotaxin messenger ribonucleic acid (mRNA) expression is increased in endothelial cells from bronchial biopsy specimens in asthmatic patients and levels are associated with AHR [
28]. Pulmonary endothelial tissue transglutaminase 2 (TG2) is upregulated in asthma and appears to be required for eosinophil recruitment to the lungs. Mice with endothelial deficient TG2 show a reduction in lung eosinophil levels in response to an allergen challenge [
29].
In summary, TEM appears to be upregulated in obstructive lung diseases and an increase in endothelial adhesion molecules is seen in both COPD and asthma. This is likely to play a role in the increased influx of inflammatory cells seen in both conditions and therefore may be important in the development of inflammation and the pathogenesis of obstructive lung disease.